Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration.

Literature DB >> 13271562

Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration.

J A BUSH, J P MAHONEY, H MARKOWITZ, C J GUBLER, G E CARTWRIGHT, M M WINTROBE.

Abstract

Entities: Chemical Disease Species

Keywords: BLOOD; COPPER/metabolism; FECES; HEPATOLENTICULAR DEGENERATION/metabolism in; URINE

Mesh：

Substances：
Copper

Year: 1955 PMID： 13271562 PMCID： PMC438760 DOI： 10.1172/JCI103232

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

14 in total

1. Metabolic studies in Wilson's disease using Cu64.

Authors: A G BEARN; H G KUNKEL
Journal: J Lab Clin Med Date: 1955-04

2. Studies on copper metabolism. XIII. Hepatolenticular degeneration.

Authors: G E CARTWRIGHT; R E HODGES; C J GUBLER; J P MAHONEY; K DAUM; M M WINTROBE; W B BEAN
Journal: J Clin Invest Date: 1954-11 Impact factor: 14.808

3. Localization of Cu64 in serum fractions following oral administration: an alteration in Wilson's disease.

Authors: A G BEARN; H G KUNKEL
Journal: Proc Soc Exp Biol Med Date: 1954-01

4. Metabolism of copper in hepatolenticular degeneration.

Authors: W T ZIMDAHL; I HYMAN; E D COOK
Journal: Neurology Date: 1953-08 Impact factor: 9.910

5. Studies on copper metabolism I. A method for the determination of copper in whole blood, red blood cells, and plasma.

Authors: C J GUBLER; M E LAHEY; H ASHENBRUCKER; G E CARTWRIGHT; M M WINTROBE
Journal: J Biol Chem Date: 1952-05 Impact factor: 5.157

6. Studies on copper metabolism. XI. Copper and iron metabolism in the nephrotic syndrome.

Authors: G E CARTWRIGHT; C J GUBLER; M M WINTROBE
Journal: J Clin Invest Date: 1954-04 Impact factor: 14.808

7. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).

Authors: D DENNY-BROWN; H PORTER
Journal: N Engl J Med Date: 1951-12-13 Impact factor: 91.245

8. Ferrokinetics in normal persons and in patients having various erythropoietic disorders.

Authors: R L HUFF; P J ELMLINGER; J F GARCIA; J M ODA; M C COCKRELL; J H LAWRENCE
Journal: J Clin Invest Date: 1951-12 Impact factor: 14.808

9. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.

Authors: H MARKOWITZ; C J GUBLER; J P MAHONEY; G E CARTWRIGHT; M M WINTROBE
Journal: J Clin Invest Date: 1955-10 Impact factor: 14.808

10. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).

Authors: I H SCHEINBERG; D GITLIN
Journal: Science Date: 1952-10-31 Impact factor: 47.728

29 in total

1. ABSORPTION OF COPPER IN MALABSORPTION SYNDROMES.

Authors: I STERNLIEB; H D JANOWITZ
Journal: J Clin Invest Date: 1964-06 Impact factor: 14.808

2. RELATION BETWEEN CIRRHOSIS AND TRACE METAL CONTENT OF LIVER WITH SPECIAL REFERENCE TO PRIMARY BILIARY CIRRHOSIS AND COPPER.

Authors: A H HUNT; R M PARR; D M TAYLOR; N G TROTT
Journal: Br Med J Date: 1963-12-14

Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration.

1. Metabolic studies in Wilson's disease using Cu64.

2. Studies on copper metabolism. XIII. Hepatolenticular degeneration.

3. Localization of Cu64 in serum fractions following oral administration: an alteration in Wilson's disease.

4. Metabolism of copper in hepatolenticular degeneration.

5. Studies on copper metabolism I. A method for the determination of copper in whole blood, red blood cells, and plasma.

6. Studies on copper metabolism. XI. Copper and iron metabolism in the nephrotic syndrome.

7. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).

8. Ferrokinetics in normal persons and in patients having various erythropoietic disorders.

9. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.

10. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).

1. ABSORPTION OF COPPER IN MALABSORPTION SYNDROMES.

2. RELATION BETWEEN CIRRHOSIS AND TRACE METAL CONTENT OF LIVER WITH SPECIAL REFERENCE TO PRIMARY BILIARY CIRRHOSIS AND COPPER.

3. OBSERVATIONS ON THE MECHANISM OF ABSORPTION OF COPPER BY THE SMALL INTESTINE.

4. Copper metabolism and the liver.

5. Effect of estrogens on copper metabolism in Wilson's disease.

6. Observations on ceruloplasmin in Wilson's disease.

7. Renal function in Wilson's disease.

8. Progressive familial choreoathetosis with cutaneous telangiectasia.

9. Studies on copper metabolism. XXIII. Portal (Laennec's) cirrhosis of the liver.

10. DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE.